The practice receives a number of safety alerts which can affect how we deliver services. Some of these alerts are also for patient’s information. Below you will find a list of alerts the practice has received and acted upon and which patients should be aware of.
Alerts are like product recalls in retail. If there is an alert requiring changes to medicines which you are taking or appliances you are using we will contact you directly to provide the correct advice and help.
ALERT 01/02/2024
Due to a measles outbreak and falling levels of vaccination uptake, there is a planned national call/recall for individuals aged 1-25 years who are outstanding dose/s of the MMR vaccine. This will be done as part of a phased approach. The current target cohort is 6-11 year olds. Please book your measles catch up when you are invited. Full protection is achieved at 2 doses. Healthcare professionals and those at risk due to being immunosuppressed should contact their GP if they wish to be vaccinated before their invite letter.
ALERT 14/12/2023
Class 3 Medicines Recall: Biocon Pharma UK Ltd., Posaconazole Biocon 100mg Gastro-resistant Tablets, EL(23)A/44
Biocon Pharma UK Limited are recalling a specific of batch Posaconazole 100mg Gastro-resistant Tablets due to an out of trend result for unspecified impurities during testing for stability.
See https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-biocon-pharma-uk-ltd-dot-posaconazole-biocon-100mg-gastro-resistant-tablets-el-23-a-slash-44
ALERT 24/11/2023
Specific brands of carbomer eye gel: recall of AACARB eye gel, AACOMER eye gel and PUROPTICS eye gel: potential risk of infection, DSI/2023/11
Specific batches of carbomer gel are being recalled as a precaution due to possible microbiological contamination.
See https://www.gov.uk/drug-device-alerts/specific-brands-of-carbomer-eye-gel-recall-of-aacarb-eye-gel-aacomer-eye-gel-and-puroptics-eye-gel-potential-risk-of-infection-dsi-slash-2023-slash-11
ALERT 20/09/2023
Class 3 Medicines Recall: Chiesi Ltd., Trimbow 87/5/9 mcg pressurised inhalation solution, EL(23)A/36
Chiesi Ltd has informed the MHRA about a potential issue with the batches listed in this notification. This is due to intermittent high results for the uniformity of delivered dose of formoterol fumarate observed during stability testing.
See https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-chiesi-ltd-dot-trimbow-87-slash-5-slash-9-mcg-pressurised-inhalation-solution-el-23-a-slash-36
ALERT 07/09/2023
Class 4 Medicines Defect Information: Colgate-Palmolive (U.K.) Limited, Duraphat 5000ppm Fluoride Toothpaste (51g), EL (23)A/35
Colgate-Palmolive (U.K.) Limited has informed the MHRA that the Patient Information Leaflet (PIL), carton and tube of the batches of Duraphat 5000ppm Fluoride Toothpaste (51g) listed above are missing information relating to the presence of allergens in the product.
See https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-colgate-palmolive-uk-limited-duraphat-5000ppm-fluoride-toothpaste-51g-el-23-a-slash-35